Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain
Status:
Withdrawn
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This is a Phase 3 study to assess the safety and efficacy of a single epidural administration
of Resiniferatoxin versus standard of care for the treatment of intractable pain associated
with cancer.